Rui Ma
- Epidemiology top 10%
- Immunology
- Infectious Diseases top 10%
- Health top 5%
- Molecular Biology
- Topics
- Virology and Viral Diseases (16 papers)Vaccine Coverage and Hesitancy (12 papers)SARS-CoV-2 and COVID-19 Research (9 papers)
- Cited by
- HealthEpidemiologyImmunology
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Rui Ma
75 papers receiving 832 citations
Peers
Comparison fields: 5 of 113
- Epidemiology 384
- Immunology 209
- Infectious Diseases 183
- Health 157
- Molecular Biology 130
Countries citing papers authored by Rui Ma
This map shows the geographic impact of Rui Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Ma more than expected).
Fields of papers citing papers by Rui Ma
This network shows the impact of papers produced by Rui Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Ma. The network helps show where Rui Ma may publish in the future.
Co-authorship network of co-authors of Rui Ma
This figure shows the co-authorship network connecting the top 25 collaborators of Rui Ma. A scholar is included among the top collaborators of Rui Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui Ma. Rui Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 8 | |
| 6 | 19 | |
| 7 | 6 | |
| 8 | 7 | |
| 9 | 10 | |
| 10 | 4 | |
| 11 | 1 | |
| 12 | 13 | |
| 13 | 2 | |
| 14 | [Varicella breakthrough infection and vaccine effectiveness with 1-dose varicella]. | 1 |
| 15 | [Changes of epidemiological characteristics of measles in Beijing before and after supplementary immunization campaigns of measles vaccine in 2010]. | 3 |
| 16 | 18 | |
| 17 | Epidemiological analysis on public health emergencies of varicella outbreak and break-through cases. | 1 |
| 18 | 13 | |
| 19 | 1 | |
| 20 | Genealogy and regional distribution of lipoprotein lipase deficiency in French-Canadians of Quebec. | 10 |
About Rui Ma
Rui Ma is a scholar working on Health, Parasitology and Epidemiology, having authored 84 papers that have together received 855 indexed citations. Recurring topics across this work include Virology and Viral Diseases (16 papers), Vaccine Coverage and Hesitancy (12 papers) and SARS-CoV-2 and COVID-19 Research (9 papers). The work is most often cited by research in Health (157 citations), Epidemiology (384 citations) and Immunology (209 citations). Rui Ma has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Jun Huang, Changyou Wu, Guozhang Xu, Qinsheng Bi, Zhengdi Zhang, Hongjun Dong, Luodan Suo, Jiang Wu, Yexiang Sun and Li Lu. Their work appears in journals such as New England Journal of Medicine, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.